Community Health Workers can improve cancer care delivery, according to new research

A novel peptide vaccine against glioblastoma, a deadly brain tumor, is offering hope to some patients thanks to the work of an international effort including Providence's Santosh Kesari, MD, PhD.

A first-of-its-kind study on the efficacy and safety of weight loss medications in the real world is helping to provide clinicians with new is helping to provide clinicians with valuable new evidence.

The procedure using the new TriClip to repair a leaky tricuspid valve was also a first in the Pacific Northwest.

Providence researchers conducted over 2400 studies in 2023, according to the 2023 Providence Research Network Annual Report

The largest study of angiosarcoma published to date, co-authored at Providence, describes the incidence and presentation patterns of angiosarcoma, a rare but potentially deadly cancer.

Two stories of how, together with our industry partners and patients, Providence is working to make the latest trials available to more people who could benefit from them.

A study led by Providence researcher Katherine Tuttle, MD, FACP, of Spokane, Washington is in the news thanks to findings around a promising new treatment for kidney disease.

The OakTree study is looking at a new COVID-19 drug to see if it can shorten the time you have symptoms. Learn more about participating.

A global study co-authored by Providence researchers shows significant promise for the treatment of Chronic lymphocytic leukemia/Small Lymphocytic Lymphoma

The Providence Research Network 2022 Annual report highlights a year of impact and breakthroughs made possible by Providence's network of researchers, caregivers, scientists and research participants.

Clinical Trials Day is celebrated annually on May 20th. This year, to celebrate the event, we’ve released our Providence Research Network annual research report.

Providence researchers receive awards for two studies of COVID-19’s impacts on colorectal cancer screenings and outcomes

Providence researchers are studying a blood-based, multi-cancer early detection test able to detect more than 50 cancer types through a single blood draw.

Evidence outlined in a new research publication co-authored by Dr. Jason Goldman of Providence Swedish could help respond to the shortage of donated organs during COVID-19.

Providence is partnering with Stand Up To Cancer on a multi-year effort called the CHAT project focused on increasing colorectal cancer screenings in communities of color.

New studies co-authored by Providence Research Network Researchers help identify drug resistance and reversal mechanisms in breast cancer

The National African Americans with MS Registry is a patient-powered research registry focused on and led by African Americans.

Clinical research at the Center for Polycystic Kidney Disease at Swedish offers hope to patients with PKD, one of the most common genetic diseases

A new report from the Providence Research Network highlights how Providence researchers are advancing the future of health and health care.

Learn how a team of Providence researchers analyzed how the protection from various COVID-19 vaccines decline over time